Smith TJ - Search Results

1

Management of Cancer Cachexia: ASCO Guideline.

Roeland EJ, Bohlke K, Baracos VE, Bruera E, Del Fabbro E, Dixon S, Fallon M, Herrstedt J, Lau H, Platek M, Rugo HS, Schnipper HH, Smith TJ, Tan W, Loprinzi CL. Roeland EJ, et al. Among authors: smith tj. J Clin Oncol. 2020 Jul 20;38(21):2438-2453. doi: 10.1200/JCO.20.00611. Epub 2020 May 20. J Clin Oncol. 2020. PMID: 32432946

2

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.

Desch CE, Lasala MR, Smith TJ, Hillner BE. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1992 Feb;10(2):200-9. doi: 10.1200/JCO.1992.10.2.200. J Clin Oncol. 1992. PMID: 1531067

3

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.

Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166. J Clin Oncol. 1995. PMID: 7666075 Clinical Trial.

4

The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women.

Smith TJ, Hillner BE. Smith TJ, et al. J Clin Oncol. 1993 Apr;11(4):771-6. doi: 10.1200/JCO.1993.11.4.771. J Clin Oncol. 1993. PMID: 8478670

5

Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.

Desch CE, Hillner BE, Smith TJ, Retchin SM. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1993 Apr;11(4):777-82. doi: 10.1200/JCO.1993.11.4.777. J Clin Oncol. 1993. PMID: 8478671

6

Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.

Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD. Hillner BE, et al. Among authors: smith tj. J Clin Oncol. 1996 Jan;14(1):70-7. doi: 10.1200/JCO.1996.14.1.70. J Clin Oncol. 1996. PMID: 8558224 Clinical Trial.

7

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.

Fetting JH, Gray R, Fairclough DL, Smith TJ, Margolin KA, Citron ML, Grove-Conrad M, Cella D, Pandya K, Robert N, Henderson IC, Osborne CK, Abeloff MD. Fetting JH, et al. Among authors: smith tj. J Clin Oncol. 1998 Jul;16(7):2382-91. doi: 10.1200/JCO.1998.16.7.2382. J Clin Oncol. 1998. PMID: 9667255 Clinical Trial.

8

American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.

Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG 3rd, Somerfield MR. Smith TJ, et al. J Clin Oncol. 1999 Mar;17(3):1080-2. doi: 10.1200/JCO.1999.17.3.1080. J Clin Oncol. 1999. PMID: 10071303

9

Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.

Bennett CL, Weeks JA, Somerfield MR, Feinglass J, Smith TJ. Bennett CL, et al. Among authors: smith tj. J Clin Oncol. 1999 Nov;17(11):3676-81. doi: 10.1200/JCO.1999.17.11.3676. J Clin Oncol. 1999. PMID: 10550166

10

Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.

Desch CE, Benson AB 3rd, Smith TJ, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Somerfield MR. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1999 Apr;17(4):1312. doi: 10.1200/JCO.1999.17.4.1312. J Clin Oncol. 1999. PMID: 10561194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,734 results

Search Page